Cáncer Colorrectal
Sky Lakes Cancer Treatment Center
Call Us (541) 274-4171 DirectionsServices we offer at this location:
¿Qué es el Cáncer
Colorrectal?
Según la American Cancer Society (Sociedad Americana de Cáncer), el cáncer colorrectal es el tercer diagnóstico de cáncer más común en hombres y mujeres en los Estados Unidos. La American Cancer Society estima que el número de cánceres colorrectales en los Estados Unidos para 2023 es de 106,970 nuevos casos de cáncer de colon y 46,050 nuevos casos de cáncer de recto. Se espera que los cánceres colorrectales causen aproximadamente 52,550 muertes en 2023.
Los cánceres colorrectales se originan en el colon o el recto (también denominado cáncer de colon o cáncer de recto dependiendo de dónde se origine el cáncer). Estos cánceres se agrupan porque tienen muchas características en común. La mayoría de los cánceres colorrectales son adenocarcinomas. Cuando los doctores hablan sobre los cánceres colorrectales, por lo general, se refieren a este tipo.
Otros tipos de tumores también pueden originarse en el colon o el recto. Entre ellos se incluyen:
- Tumores carcinoides
- Tumores de estroma gastrointestinal (GIST por sus siglas en
inglés) - Linfomas
- Sarcomas
Why is screening important?
Colorectal cancer screenings has lowered the overall colorectal cancer death rate the last several decades. In the last decade, improvements in colorectal cancer treatment have increased survival rates.
Colonoscopies allow doctors to remove suspicious polyps before they become cancerous during screenings and screenings help detect cancers early when they are easier to treat.
According to the ACS the five-year relative survival rate for colon or rectal cancer is 80%. This means that people who have colorectal cancer are about 80% as likely to live at least five years after diagnosis as people who don’t have that cancer. This can also give you a better understanding of how likely treatment will be successful.
Screening for Colorectal Cancers
Colonoscopies are often the type of colorectal preventative screenings most people think about, but they aren’t your only option. There are stool-based tests and other visual (structural) exams.
These are the most common forms of colorectal cancer screening tests
Colonoscopy
The doctor uses a long, thin, flexible, lighted tube to look for polyps and cancer inside the rectum and entire colon. During this test, the doctor can remove suspicious polyps and cancers. Colonoscopies may also be used as a follow up test for other tests in this list.
You should get a colonoscopy every 10 years unless otherwise instructed by your care team.
CT colonography (virtual colonoscopy)
This test uses x-rays of the entire colon. It’s also considered a “virtual colonoscopy.”
Virtual colonoscopies should be repeated every five years.
Flexible sigmoidoscopy
This test is similar to a colonoscopy, but instead flexible sigmoidoscopy only screens in the rectum and lower third of the colon.
Flexible sigmoidoscopies should be repeated every five years.
Stool tests
There are three types of stool-test: guaiac-based fecal occult blood test (gFOBT), fecal immunochemical test (FIT), and the FIT-DNA test.
These tests check for blood or altered DNA in stool samples.
How often should these tests be repeated?
- Highly sensitive fecal immunochemical test (FIT) every year
- Highly sensitive guaiac-based fecal occult blood test (gFOBT) every year
- Multi-targeted stool DNA test (mt-sDNA) every three years
What is the difference between screening with a stool-based test and a colonoscopy?
Stool tests are DNA tests that detect cell changes or blood in the stool that may be caused by cancerous or precancerous polyps. Colonoscopies can prevent cancer from developing by removing polyps and can detect cancer at an early stage.
Who should screen for colorectal cancer?
All adults between ages 45 and 75 should regularly screen for colorectal cancer.
Men have a 1 in 23 risk for developing colorectal cancer in their lifetime and women have a 1 in 26 risk. Each person’s risk may be higher or lower depending on their personal risk.
The ACS says that people of average risk should start screening for colorectal cancer at age 45. People who are in good health with a life expectancy of more than 10 years should continue regular screening through age 75. Screening over the age of 75 should be based on personal choice and health history.
People who are at increased risk for colorectal cancer should talk to their doctor about screening.
People at average risk for colorectal cancer:
- Do not have a personal history of colorectal cancer or certain types of polyps.
- Do not have a family history of colorectal cancer.
- Do not have a history of inflammatory bowel disease, ulcerative colitis, or Chron’s disease.
- Do not have confirmed or suspected hereditary colorectal cancer syndrome (Familial adenomatous polyposis or Lynch Syndrome).
- Do not have a personal history of prior cancer that was treated with radiation to the abdomen or pelvic area.
Insurance coverage for colorectal cancer screening
The Affordable Care Act (ACA) requires private insurers and Medicare to cover the costs of colorectal screening tests because these tests are recommended by the United States Preventative Services Task Force. The ACA states that there should be no out-of-pocket costs for patients like copays or deductibles. This law covers a range of colorectal cancer screening tests, not just colonoscopies.
Some private insurance companies may cover the cost of the screening test, but not other services rendered during the screening or screenings done by out-of-network providers. You should review your health insurance plan and call your insurer if you aren’t sure about what is covered.